Your message has been sent.
Your message could not be sent at this time.
Your child should not receive any formulation of LUPRON DEPOT-PED if he/she has experienced any type of allergic reaction to LUPRON DEPOT-PED or similar drugs.
Females who are or may become pregnant should not receive any formulation of LUPRON DEPOT-PED.
LUPRON DEPOT-PED is not for children under 2 years of age.
View the full Prescribing Information for LUPRON DEPOT-PED.
Reference: LUPRON DEPOT-PED [package insert]. North Chicago, IL: Abbott Laboratories.
202-653313
Talk to your child's doctor about your child's medical history and all other medicines that your child takes.
Convulsions have been observed in patients taking leuprolide acetate, including patients who have a history of seizures, epilepsy, or brain disorders (related to blood vessels, nerves, or tumors), and in patients who are taking medications that have been associated with convulsions. Convulsions have also been reported in patients without any of these conditions.
During the first weeks of treatment, signs of puberty, such as vaginal bleeding, may occur. This is a common initial effect of the drug. Notify your child's doctor if signs/symptoms of puberty continue beyond the second month of treatment.
After the injection, some pain and irritation is expected; however, if more severe symptoms occur or if any new, unusual, or worsened symptoms develop, contact your child's doctor.
Your child's initial response to LUPRON DEPOT-PED should be monitored, as well as their continued response during treatment, as clinically needed.
It is important that you keep your child's doctor appointments and follow the prescribed injection schedule. Your child's pubertal development could begin again if injections are missed.
The most common side effects with LUPRON DEPOT-PED and similar drugs are pain; acne; injection site reactions, including pain, swelling, and abscess; rash, including a painful rash with fever, blisters/sores, and facial swelling; vaginitis/vaginal bleeding/vaginal discharge; increased weight; altered mood; general pain; headache; fluctuating emotions; and hot flushes/sweating.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
If you cannot afford your medication, contact www.pparx.org or call the toll-free phone number (1-888-4PPANOW) for assistance.
LUPRON DEPOT-PED 7.5 mg, 11.25 mg and 15 mg for 1-month and 11.25 mg and 30 mg for 3-month administration are prescribed for the treatment of children with central precocious puberty (CPP).
Doctors may diagnose children with CPP when signs of sexual maturity begin to develop in girls under the age of 8 or boys under the age of 9. Your doctor should perform tests to rule out possible causes of CPP that would require different treatment (e.g., tumors).
LUPRON DEPOT-PED must be administered under the supervision of a physician.
Learning more about what to expect with LUPRON DEPOT-PED treatment is an important part of preparing you and your child for CPP therapy. Be sure to put together a list of all the questions you and your child have (both before starting therapy and while therapy is ongoing). This list of questions can be a good starting point. Remember, LUPRON DEPOT-PED must be administered under the supervision of a physician.
Know how your child should respond and what signs to look out for.
Keep track of pubertal development to ensure your child is responding properly to treatment.
Keeping up with therapy and monitoring progress are keys to effective treatment.
Learn how to answer your child’s questions about CPP and its treatment.